Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Interactive Journal of Medical Research

Date Submitted: May 17, 2020
Date Accepted: Sep 12, 2020

The final, peer-reviewed published version of this preprint can be found here:

Time to Treatment and In-Hospital Major Adverse Cardiac Events Among Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention (PCI) According to the 24/7 Primary PCI Service Registry in Iran: Cross-Sectional Study

Nozari Y, Geraiely B, Alipasandi K, Mortazavi SH, Omidi N, Aghajani H, Amirzadegan A, Pourhoseini H, Salarifar M, Alidoosti M, Haji-Zeinali AM, Nematipour E, Nomali M

Time to Treatment and In-Hospital Major Adverse Cardiac Events Among Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention (PCI) According to the 24/7 Primary PCI Service Registry in Iran: Cross-Sectional Study

Interact J Med Res 2020;9(4):e20352

DOI: 10.2196/20352

PMID: 33325826

PMCID: 7773509

Time to Treatment and Major Adverse Cardio-cerebrovascular Events among Patients with ST-segment Elevation Myocardial Infarction (STEMI) Underwent Primary Percutaneous Coronary Intervention (PCI) according to Tehran Heart Center`s 24/7 Primary PCI Service Registry in Iran: a Cross- sectional Study

  • Younes Nozari; 
  • Babak Geraiely; 
  • Kian Alipasandi; 
  • Seyedeh Hamideh Mortazavi; 
  • Negar Omidi; 
  • Hassan Aghajani; 
  • Alireza Amirzadegan; 
  • Hamidreza Pourhoseini; 
  • Mojtaba Salarifar; 
  • Mohammad Alidoosti; 
  • Ali Mohammad Haji-Zeinali; 
  • Ebrahim Nematipour; 
  • Mahin Nomali

ABSTRACT

Background:

Performing primary percutaneous coronary intervention (PCI), as a preferred reperfusion strategy, for patients with ST-segment elevation myocardial infarction (STEMI) may be associated with major adverse cardio-cerebrovascular events (MACCEs). Thus, timely performing primary PCI has been emphasized in order to improve outcomes. Despite guideline recommendations on trying to reduce door-to-balloon (D2B) time of less than 90 minutes in order to reduce mortality, less attention has been paid to other components of time to treatment such as symptom-to-balloon (S2B) time as an indicator of the total ischemic time, which constitute of symptom-to-door (S2D) time and D2B, on clinical outcomes of patients with STEMI underwent primary PCI.

Objective:

We aimed to determine the association between each component of time to treatment (i.e. S2B time, D2B time and S2B time) and in-hospital MACCEs among patients with STEMI underwent primary PCI.

Methods:

In this observational study, according to prospective primary PCI 24/7 service registry, adult patients with STEMI underwent primary PCI in one of the six catheterization laboratories of the Tehran Heart Center from November 2015 to August 2019 were studied. Those patients who treated with fibrinolytic and having incomplete data regarding treatment times and in-hospital MACCEs were excluded from the analysis process. The primary outcome was in-hospital MACCEs which was a composite index consisting of cardiac death, revascularization (i.e. target vessel revascularization (TVR) / target lesion revascularization (TLR), MI, and stroke which was compared at different levels of time to treatment (i.e. S2D & D2B < 90 and ≥ 90 minutes, and S2B time <180 and ≥180 minutes). Data were analyzed by SPSS software version 24, by descriptive statistics such as frequency, percentage, mean and standard deviation, and statistical tests such as chi-square, t-test, univariate and multivariate binary logistic regression with a significance level of less than .05 and 95% CI for odds ratio (OR).

Results:

Data from 2,823 out of 3204 patients were analyzed with a mean age of 59.6 (11/6) years and 79.5% of male sex (completion rate: 88.1%). The median of DBT was 55 (40-92) minutes and DBT ≤ 90 minutes was seen among the most of the patients. While the median of SDT and SBT were 258(108-574) and 355(180-720) minutes, respectively. And, the low proportion of SDT ≤ 90 minutes and SBT ≤ 180 minutes were observed among the study patients (20.5 % and 24.5 %, respectively). Overall, 2.4% of the patients experienced in-hospital MACCEs, and cardiac death (1.6%) was the most common cardiac outcome. In the univariate analysis, S2B time predicted the in-hospital MACCEs (OR = 2.2; 95% CI: 1.1-4.4, P =.029), while S2D time (OR = 1.4; 95% CI: 0.7-2.6; P=.343) and D2B time (OR = 1.1; 95% CI: 0.6-1.8, P= .769) were not associated with in-hospital MACCES. In the multivariate analysis, only S2B time ≥ 180 minutes was associated with in-hospital MACCEs and was a predictor of in-hospital MACCEs (OR = 2.3; 95% CI: 1.1-5.2, P =.041).

Conclusions:

From different components of time to treatment, longer S2B time was associated with higher in-hospital MACCEs in the present study. Efforts should be made to shorten S2B time in order to improve in-hospital MACCEs.


 Citation

Please cite as:

Nozari Y, Geraiely B, Alipasandi K, Mortazavi SH, Omidi N, Aghajani H, Amirzadegan A, Pourhoseini H, Salarifar M, Alidoosti M, Haji-Zeinali AM, Nematipour E, Nomali M

Time to Treatment and In-Hospital Major Adverse Cardiac Events Among Patients With ST-Segment Elevation Myocardial Infarction Who Underwent Primary Percutaneous Coronary Intervention (PCI) According to the 24/7 Primary PCI Service Registry in Iran: Cross-Sectional Study

Interact J Med Res 2020;9(4):e20352

DOI: 10.2196/20352

PMID: 33325826

PMCID: 7773509

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.